second-line - Globe Thesis

Keyword [second-line] Result: 41 - 60 \| Page: 3 of 7
41.	New Progress Of Drug Treatment In Relapsed Small Cell Lung Cancer
42.	Antiangiogenic Agents Combined With Chemotherapy Treatment Of Advanced Non-small-cell Lung Cancer: A Meta-analysis
43.	Efficacy And Survival Analysis Of Second-line Chemotherapy For Advanced Non-small Cell Lung Cancer
44.	Comparative Study Of R-GEMOX And RICE Regimens As Second-line Treatments For Refractory Or Relapsed DLBCL
45.	Clinical Curative Effect Study Of First-Line And Second-Line Treatment By Gefitinib For Patients With Non-Small-Cell Lung Cancer
46.	Survival Influence Factors Of Patients With Advanced Non-small Cell Lung Cancer And Preliminary Analysis Of Drug Efficacy In The Practical Work
47.	Clinical Research Of Etoposide Soft Capsules For Second-line Monotherapy Of Elderly Patients With Extensive-stage Small Cell Lung Cancer
48.	Efficacy And Safety Of EGFR Tyrosine Kinase Inhibitor Monotherapy With Docetaxel Monotherapy In Previously Treated Advanced Non-Small-Cell Lung Cancer: A Meta-analysis
49.	Second-Line Platinum-Based Chemotherapy Regimens For Advanced Esophageal Carcinoma
50.	Analysis On The Factors Related With Lower Response Rates To Second-line Chemotherapy For Colorectal Cancer
51.	The Clinical Observation Of Gemcitabine Plus Vinorelbine For Second-Line Treatment Of Metastatic Nasopharyngeal Carcinoma
52.	The Study On First-line And Second-line Treatment Of Metastatic Or Recurrent Nasopharyngeal Carcinoma
53.	Comparison Of Icotinib Versus Docetaxel As Second-line Treatment Of Advanced Lung Adenocarcinoma
54.	Efficacy And Predictors Of 178 Advanced Non-small Lung Cancer Patients Undergoing Different Second-line Chemotherapeutic Regimens
55.	Combined Therapy And Prognosis Analysis Of Small Cell Lung Cancer In General Hospital Oncology Department For Nearly 4 Years
56.	Clinical Observation Of Raltitrexed-based Versus FOLFIRI In The Second-line Treatment Of Advanced Colorectal Cancer
57.	Rapid Detection Of First-and Second-Line Drug Resistance In Mycobacterium Tuberculosis Using Tag Array
58.	Epidemiology And Molecular Characteristics Of Second-line Drug-resistance Among MDR-TB Isolates In Chongqing,China
59.	A Prospective Clinical Study Of Low-dose Decitabine In The Management Of First-and Second-line Treatments Resis/relap ITP Patients
60.	Clinical Observation Of Sunitinib As Second. Line Treatment For Gastrointestinal Stromal Tumor
<<First <Prev Next> Last>> Jump to